7Baggers

Couchbase Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Long-Term Debt  
20210731 20211031 20220131 20220430 20220731 20221031 20230131 20230430 20230731 20231031 20240131 20240430 20240731 20241031 20250131 20250430 20250731 034.1868.36102.53136.71170.89205.07239.25Milllion

Couchbase Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 
                   
  assets:                 
  current assets                 
  cash and cash equivalents44,110,000 28,046,000 30,536,000 33,031,000 62,607,000 51,975,000 41,351,000 46,907,000 41,437,000 46,240,000 40,446,000 38,781,000 46,338,000 47,672,000 95,688,000 141,440,000 239,246,000 
  short-term investments98,112,000 113,779,000 116,635,000 108,908,000 93,526,000 108,220,000 112,281,000 109,719,000 124,361,000 117,403,000 127,856,000 138,469,000 145,767,000 153,409,000 110,266,000 66,195,000 14,321,000 
  accounts receivable42,643,000 43,781,000 49,242,000 28,514,000 31,263,000 34,580,000 44,848,000 30,494,000 32,453,000 42,212,000 39,847,000 22,530,000 29,018,000 24,622,000 36,696,000 22,525,000 20,183,000 
  deferred commissions17,694,000 16,921,000 16,774,000 13,297,000 13,187,000 13,233,000 15,421,000 12,874,000 12,787,000 12,814,000 13,096,000 12,154,000 11,525,000 11,548,000 11,783,000 9,215,000 8,645,000 
  prepaid expenses and other current assets9,493,000 11,772,000 15,206,000 10,551,000 10,092,000 10,307,000 10,385,000 7,450,000 8,034,000 6,839,000 8,234,000 7,773,000 9,655,000 8,014,000 8,559,000 8,191,000 8,099,000 
  total current assets212,052,000 214,299,000 228,393,000 194,301,000 210,675,000 218,315,000 224,286,000 207,444,000 219,072,000 225,508,000 229,479,000 219,707,000 242,303,000 245,265,000 262,992,000 247,566,000 290,494,000 
  property and equipment11,110,000 10,167,000 7,214,000 7,000,000 7,053,000 6,113,000 5,327,000 9,630,000 8,581,000 8,032,000 7,430,000 6,731,000 5,639,000 4,341,000 4,288,000 4,983,000 5,578,000 
  operating lease right-of-use assets6,739,000 3,312,000 3,935,000 5,497,000 3,497,000 4,135,000 4,848,000 5,259,000 5,620,000 6,233,000 6,940,000 7,021,000 7,696,000 7,668,000    
  deferred commissions, noncurrent19,060,000 17,702,000 19,602,000 14,485,000 13,603,000 12,562,000 11,400,000 7,896,000 7,736,000 8,089,000 7,524,000 7,592,000 7,798,000 8,267,000 8,243,000 5,885,000 5,394,000 
  other assets1,473,000 1,479,000 1,454,000 1,176,000 1,119,000 1,446,000 1,891,000 1,760,000 2,645,000 1,608,000 1,666,000 1,247,000 1,334,000 1,453,000 1,219,000 1,255,000 1,316,000 
  total assets250,434,000 246,959,000 260,598,000 222,459,000 235,947,000 242,571,000 247,752,000 231,989,000 243,654,000 249,470,000 253,039,000 242,298,000 264,770,000 266,994,000 276,742,000 259,689,000 302,782,000 
  liabilities and stockholders’ equity:                 
  current liabilities                 
  accounts payable4,493,000 4,565,000 2,186,000 4,724,000 5,031,000 4,071,000 4,865,000 3,172,000 3,156,000 6,865,000 1,407,000 3,523,000 5,579,000 2,640,000 1,923,000 3,518,000 7,153,000 
  accrued compensation and benefits16,605,000 9,764,000 21,091,000 12,323,000 14,123,000 8,939,000 18,116,000 9,124,000 10,887,000 8,495,000 12,641,000 9,045,000 10,530,000 8,025,000 16,143,000 9,926,000 9,020,000 
  other accrued expenses8,095,000 7,311,000 8,443,000 3,981,000 3,373,000 3,814,000 4,581,000 3,399,000 4,874,000 4,813,000 6,076,000 3,314,000 4,103,000 2,946,000 3,231,000   
  operating lease liabilities1,053,000 800,000 1,356,000 2,150,000 2,670,000 3,106,000 3,208,000 2,980,000 2,984,000 3,060,000 3,117,000 3,043,000 3,075,000 2,717,000    
  deferred revenue86,689,000 92,178,000 94,252,000 67,996,000 81,906,000 89,619,000 81,736,000 71,529,000 79,721,000 78,540,000 71,716,000 58,039,000 67,139,000 68,466,000 69,010,000 48,226,000 48,980,000 
  total current liabilities116,935,000 114,618,000 127,328,000 91,174,000 107,103,000 109,549,000 112,506,000 90,204,000 101,622,000 101,773,000 94,957,000 76,964,000 90,426,000 84,794,000 90,307,000 64,200,000 68,728,000 
  operating lease liabilities, noncurrent7,131,000 2,943,000 2,960,000 3,678,000 1,170,000 1,388,000 2,078,000 2,742,000 3,271,000 3,873,000 4,543,000 4,658,000 5,491,000 5,627,000    
  deferred revenue, noncurrent2,359,000 3,248,000 2,694,000 829,000 1,031,000 2,572,000 2,747,000 3,775,000 3,219,000 2,874,000 3,275,000 2,577,000 2,467,000 2,289,000 2,713,000 2,726,000 5,356,000 
  total liabilities126,425,000 120,809,000 132,982,000 95,681,000 109,304,000 113,509,000 117,331,000 96,721,000 108,112,000 108,520,000 102,775,000 84,199,000 98,384,000 92,710,000 93,527,000 68,221,000 100,359,000 
  commitments and contingencies                 
  stockholders’ equity                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of july 31, 2025 and january 31, 2025; zero shares issued outstanding as of july 31, 2025 and january 31, 2025                 
  common stock                 
  additional paid-in capital730,788,000 708,941,000 692,812,000 676,360,000 658,165,000 640,931,000 621,024,000 604,637,000 588,845,000 573,791,000 561,547,000 553,336,000 544,614,000 536,981,000 525,392,000 520,243,000 515,245,000 
  accumulated other comprehensive income-2,000 200,000 116,000 119,000 27,000 -215,000 56,000    -807,000    -195,000 -29,000  
  accumulated deficit-606,777,000 -582,991,000 -565,312,000 -549,701,000 -531,549,000 -511,654,000 -490,659,000 -469,257,000 -453,002,000 -432,351,000 -410,476,000 -393,862,000 -377,185,000 -361,816,000 -341,982,000 -328,746,000 -312,822,000 
  total stockholders’ equity124,009,000 126,150,000 127,616,000 126,778,000 126,643,000 129,062,000 130,421,000 135,268,000 135,542,000 140,950,000 150,264,000 158,099,000 166,386,000 174,284,000 183,215,000 191,468,000 202,423,000 
  total liabilities and stockholders’ equity250,434,000 246,959,000 260,598,000 222,459,000 235,947,000 242,571,000 247,752,000 231,989,000 243,654,000 249,470,000 253,039,000 242,298,000 264,770,000 266,994,000    
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of april 30, 2025 and january 31, 2025; zero shares issued outstanding as of april 30, 2025 and january 31, 2025                 
  assets                 
  liabilities and stockholders’ equity                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of january 31, 2025 and 2024; zero shares issued and outstanding as of january 31, 2025 and 2024                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of october 31, 2024 and january 31, 2024; zero shares issued outstanding as of october 31, 2024 and january 31, 2024                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of july 31, 2024 and january 31, 2024; zero shares issued outstanding as of july 31, 2024 and january 31, 2024                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of april 30, 2024 and january 31, 2024; zero shares issued outstanding as of april 30, 2024 and january 31, 2024                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of january 31, 2024 and 2023; zero shares issued and outstanding as of january 31, 2024 and 2023                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of october 31, 2023 and january 31, 2023; zero shares issued outstanding as of october 31, 2023 and january 31, 2023                 
  accumulated other comprehensive loss       -112,000 -301,000 -490,000  -1,375,000 -1,043,000 -881,000    
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of july 31, 2023 and january 31, 2023; zero shares issued outstanding as of july 31, 2023 and january 31, 2023                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of april 30, 2023 and january 31, 2023; zero shares issued outstanding as of april 30, 2023 and january 31, 2023                 
  other liabilities              507,000 1,295,000 1,312,000 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of january 31, 2023 and 2022; zero shares issued and outstanding as of january 31, 2023 and 2022                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of october 31, 2022 and january 31, 2022; zero shares issued outstanding as of october 31, 2022 and january 31, 2022                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of july 31, 2022 and january 31, 2022; zero shares issued outstanding as of july 31, 2022 and january 31, 2022                 
  preferred stock, 0.00001 par value; 200,000,000 shares authorized as of april 30, 2022 and january 31, 2022; zero shares issued outstanding as of april 30, 2022 and january 31, 2022                 
  liabilities, redeemable convertible preferred stock and stockholders’ equity                 
  long-term debt                24,963,000 
  redeemable convertible preferred stock                 
  preferred stock, 0.00001 par value; 200,000,000 shares and zero shares authorized as of january 31, 2022 and 2021, respectively; zero shares issued and outstanding as of january 31, 2022 and 2021,                 
  total liabilities, redeemable convertible preferred stock and stockholders’ equity              276,742,000 259,689,000 302,782,000 
  other accrued liabilities               2,530,000 3,575,000 
  preferred stock, 0.00001 par value; 200,000,000 and zero shares authorized as of october 31, 2021 and january 31, 2021, respectively; zero shares issued outstanding as of october 31, 2021 and january 31, 2021, respectively                 
  preferred stock, 0.00001 par value; 200,000,000 and 0 shares authorized as of july 31, 2021 and january 31, 2021, respectively; 0 shares issued outstanding as of july 31, 2021 and january 31, 2021, respectively                 

We provide you with 20 years of balance sheets for Couchbase stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Couchbase. Explore the full financial landscape of Couchbase stock with our expertly curated balance sheets.

The information provided in this report about Couchbase stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.